Viewing Study NCT04902261


Ignite Creation Date: 2025-12-24 @ 12:11 PM
Ignite Modification Date: 2025-12-27 @ 9:32 PM
Study NCT ID: NCT04902261
Status: UNKNOWN
Last Update Posted: 2023-09-01
First Post: 2021-05-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Recurrent Pancreatic Cancer
Sponsor: Changhai Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module